Cardiometabolic risk factors in Iranian adults in comparison to a Western population: The Isfahan Healthy Heart Programme

Nizal Sarrafzadegan(Isfahan University of Medical Sciences), Aliakbar Tavasolli, Zahra Dana Siadat(Mashhad University of Medical Sciences), Mojgan Gharipour, Roya Kelishadi(Isfahan University of Medical Sciences), Asgari Sedigheh(Isfahan University of Medical Sciences)
International Journal of Cardiology
October 1, 2011
10.1016/j.ijcard.2011.08.594
Cited by 0

Related Papers

Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
|The Lancet|2019|2k
Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries
|New England Journal of Medicine|2014|993
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial
|The Lancet|2019|284
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE)
|EP Europace|2017|137
White Rice Consumption and CVD Risk Factors among Iranian Population
|Journal of Health Population and Nutrition|2013|101